Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled Release Ropivacaine for Post‑Laparoscopic Incision Analgesia (Phase II)
CTR20222804Phase 2Completed
- Sponsor
- Libang Zhaoxin Biotechnology
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in postoperative pain, sponsored by Libang Zhaoxin Biotechnology. Started Oct 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20222804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222804.